Overview

A Prospective Surveillance Trial to Evaluate the Safety of Optison in Clinical Practice.

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This prospective surveillance trial will gather safety information for Optison when it is used in routine practice.
Phase:
Phase 4
Details
Lead Sponsor:
GE Healthcare